{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:10:46Z","timestamp":1790730646614,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0F8516N"],"award-info":[{"award-number":["G0F8516N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["#10810"],"award-info":[{"award-number":["#10810"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002913","name":"Vlaamse Overheid","doi-asserted-by":"publisher","award":["IWT 135043"],"award-info":[{"award-number":["IWT 135043"]}],"id":[{"id":"10.13039\/501100002913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00401-019-02053-5","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T19:03:00Z","timestamp":1565809380000},"page":"913-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["A\u03b2-induced acceleration of Alzheimer-related \u03c4-pathology spreading and its association with prion protein"],"prefix":"10.1007","volume":"138","author":[{"given":"Luis Arag\u00e3o","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Andrea","family":"Hipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet","family":"Rijal Upadhaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ospitalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta J.","family":"Koper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Largo-Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Uytterhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reichwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A. F.","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Feederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Staufenbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"2053_CR1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1523\/JNEUROSCI.4586-11.2012","volume":"32","author":"D Abramowski","year":"2012","unstructured":"Abramowski D, Rabe S, Rijal Upadhaya A, Reichwald J, Danner S, Staab D et al (2012) Transgenic expression of intraneuronal Abeta42 but not Abeta40 leads to cellular Abeta lesions, degeneration and functional impairment without typical Alzheimer\u2019s disease pathology. J Neurosci 32:1273\u20131283","journal-title":"J Neurosci"},{"key":"2053_CR2","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Zschr Psych 64:146\u2013148","journal-title":"Allg Zschr Psych"},{"key":"2053_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42:631\u2013639","journal-title":"Neurology"},{"key":"2053_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2990.2011.01244.x","volume":"38","author":"J Attems","year":"2012","unstructured":"Attems J, Thomas A, Jellinger K (2012) Correlations between cortical and subcortical tau pathology. Neuropathol Appl Neurobiol 38:582\u2013590","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2053_CR5","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1073\/pnas.0911829107","volume":"107","author":"C Balducci","year":"2010","unstructured":"Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E et al (2010) Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA 107:2295\u20132300","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0304-3940(93)90590-H","volume":"162","author":"C Bancher","year":"1993","unstructured":"Bancher C, Braak H, Fischer P, Jellinger KA (1993) Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer\u2019s and Parkinson\u2019s disease patients. Neurosci Lett 162:179\u2013182","journal-title":"Neurosci Lett"},{"key":"2053_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"2053_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","volume":"1","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213\u2013216","journal-title":"Brain Pathol"},{"key":"2053_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2053_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) Alzheimer\u2019s pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol 121:589\u2013595","journal-title":"Acta Neuropathol"},{"key":"2053_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","volume":"121","author":"H Braak","year":"2011","unstructured":"Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer\u2019s disease in individuals under thirty. Acta Neuropathol 121:171\u2013181","journal-title":"Acta Neuropathol"},{"key":"2053_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathological process in Alzheimer\u2019s disease: age categories 1\u00a0year to 100 years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"2053_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.apha.2017.09.007","volume":"82","author":"AH Brody","year":"2018","unstructured":"Brody AH, Strittmatter SM (2018) Synaptotoxic signaling by amyloid beta oligomers in Alzheimer\u2019s disease through prion protein and mGluR5. Adv Pharmacol 82:293\u2013323","journal-title":"Adv Pharmacol"},{"key":"2053_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Buee","year":"2000","unstructured":"Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Brain Res Rev"},{"key":"2053_CR15","doi-asserted-by":"publisher","first-page":"e12692","DOI":"10.1111\/acel.12692","volume":"17","author":"B Caballero","year":"2018","unstructured":"Caballero B, Wang Y, Diaz A, Tasset I, Juste YR, Stiller B et al (2018) Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell 17:e12692","journal-title":"Aging Cell"},{"key":"2053_CR16","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2015.04.043","volume":"11","author":"S Calafate","year":"2015","unstructured":"Calafate S, Buist A, Miskiewicz K, Vijayan V, Daneels G, de Strooper B et al (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11:1176\u20131183","journal-title":"Cell Rep"},{"key":"2053_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J et al (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2:306\u2013314","journal-title":"EMBO Mol Med"},{"key":"2053_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1021\/cn400085q","volume":"4","author":"RJ Chen","year":"2013","unstructured":"Chen RJ, Chang WW, Lin YC, Cheng PL, Chen YR (2013) Alzheimer\u2019s amyloid-beta oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway. ACS Chem Neurosci 4:1287\u20131296","journal-title":"ACS Chem Neurosci"},{"key":"2053_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913","journal-title":"Nat Cell Biol"},{"key":"2053_CR20","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL (2018) The amyloid-beta oligomer hypothesis: beginning of the third decade. J Alzheimers Dis 64:S567\u2013S610","journal-title":"J Alzheimers Dis"},{"key":"2053_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/acn3.730","volume":"6","author":"TO Cox","year":"2019","unstructured":"Cox TO, Gunther EC, Brody AH, Chiasseu MT, Stoner A, Smith LM et al (2019) Anti-PrP(C) antibody rescues cognition and synapses in transgenic alzheimer mice. Ann Clin Transl Neurol 6:554\u2013574","journal-title":"Ann Clin Transl Neurol"},{"key":"2053_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fncel.2015.00416","volume":"9","author":"A De Mario","year":"2015","unstructured":"De Mario A, Castellani A, Peggion C, Massimino ML, Lim D, Hill AF et al (2015) The prion protein constitutively controls neuronal store-operated Ca(2+) entry through Fyn kinase. Front Cell Neurosci 9:416","journal-title":"Front Cell Neurosci"},{"key":"2053_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2990.2000.00239.x","volume":"26","author":"MM Esiri","year":"2000","unstructured":"Esiri MM, Carter J, Ironside JW (2000) Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 26:273\u2013284","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2053_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.13514","volume":"137","author":"C Falker","year":"2016","unstructured":"Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C et al (2016) Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem 137:88\u2013100","journal-title":"J Neurochem"},{"key":"2053_CR25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szego EM et al (2017) alpha-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 20:1569\u20131579","journal-title":"Nat Neurosci"},{"key":"2053_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s004010000271","volume":"101","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ et al (2001) Prion protein expression in senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 101:49\u201356","journal-title":"Acta Neuropathol"},{"key":"2053_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nbt0502-473","volume":"20","author":"S Fredriksson","year":"2002","unstructured":"Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM et al (2002) Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 20:473\u2013477","journal-title":"Nat Biotechnol"},{"key":"2053_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523\u2013527","journal-title":"Nature"},{"key":"2053_CR29","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","volume":"30","author":"DA Gimbel","year":"2010","unstructured":"Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA et al (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367\u20136374","journal-title":"J Neurosci"},{"key":"2053_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491\u20131495","journal-title":"Science"},{"key":"2053_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/pri.18988","volume":"6","author":"HH Griffiths","year":"2012","unstructured":"Griffiths HH, Whitehouse IJ, Hooper NM (2012) Regulation of amyloid-beta production by the prion protein. Prion 6:217\u2013222","journal-title":"Prion"},{"key":"2053_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","volume":"35","author":"LT Grinberg","year":"2009","unstructured":"Grinberg LT, Rub U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406\u2013416","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2053_CR33","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084\u20136089","journal-title":"J Biol Chem"},{"key":"2053_CR34","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"issue":"145\u2013158","key":"2053_CR35","first-page":"e8","volume":"26","author":"EC Gunther","year":"2019","unstructured":"Gunther EC, Smith LM, Kostylev MA, Cox TO, Kaufman AC, Lee S et al (2019) Rescue of transgenic Alzheimer\u2019s pathophysiology by polymeric cellular prion protein antagonists. Cell Rep 26(145\u2013158):e8","journal-title":"Cell Rep"},{"key":"2053_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/359322a0","volume":"359","author":"C Haass","year":"1992","unstructured":"Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL et al (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322\u2013325","journal-title":"Nature"},{"key":"2053_CR37","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1073\/pnas.0703793104","volume":"104","author":"G Habicht","year":"2007","unstructured":"Habicht G, Haupt C, Friedrich RP, Hortschansky P, Sachse C, Meinhardt J et al (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci USA 104:19232\u201319237","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L et al (2018) Amyloid-beta plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29\u201338","journal-title":"Nat Med"},{"key":"2053_CR39","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nn1302","volume":"7","author":"MC Herzig","year":"2004","unstructured":"Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD et al (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954\u2013960","journal-title":"Nat Neurosci"},{"key":"2053_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102","journal-title":"Science"},{"key":"2053_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577\u2013580","journal-title":"J Histochem Cytochem"},{"key":"2053_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","volume":"23","author":"NW Hu","year":"2018","unstructured":"Hu NW, Corbett GT, Moore S, Klyubin I, O\u2019Malley TT, Walsh DM et al (2018) Extracellular forms of Abeta and tau from iPSC models of Alzheimer\u2019s disease disrupt synaptic plasticity. Cell Rep 23:1932\u20131938","journal-title":"Cell Rep"},{"key":"2053_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566\u2013572","journal-title":"Br J Psychiatry"},{"key":"2053_CR44","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","volume":"177","author":"DE Hurtado","year":"2010","unstructured":"Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ et al (2010) A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am J Pathol 177:1977\u20131988","journal-title":"Am J Pathol"},{"key":"2053_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National institute on aging\u2014Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313","journal-title":"Alzheimers Dement"},{"key":"2053_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00401-002-0547-3","volume":"104","author":"K Ishizawa","year":"2002","unstructured":"Ishizawa K, Komori T, Shimazu T, Yamamoto T, Kitamoto T, Shimazu K et al (2002) Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann\u2013Straussler\u2013Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol 104:342\u2013350","journal-title":"Acta Neuropathol"},{"key":"2053_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell 142:387\u2013397","journal-title":"Cell"},{"key":"2053_CR48","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","volume":"69","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Lane E, Vincent I, Otvos L Jr, Hoffmann R, Davies P (1997) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer\u2019s disease. J Neurochem 69:2087\u20132095","journal-title":"J Neurochem"},{"key":"2053_CR49","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.22615","volume":"70","author":"M Jucker","year":"2011","unstructured":"Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70:532\u2013540","journal-title":"Ann Neurol"},{"key":"2053_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489","journal-title":"Science"},{"key":"2053_CR51","first-page":"16857-71a","volume":"32","author":"M Larson","year":"2012","unstructured":"Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA et al (2012) The complex PrP(c)\u2013Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer\u2019s disease. J Neurosci 32:16857-71a","journal-title":"J Neurosci"},{"key":"2053_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40478-016-0317-4","volume":"4","author":"DH Lau","year":"2016","unstructured":"Lau DH, Hogseth M, Phillips EC, O\u2019Neill MJ, Pooler AM, Noble W et al (2016) Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer\u2019s disease. Acta Neuropathol Commun 4:49","journal-title":"Acta Neuropathol Commun"},{"key":"2053_CR53","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128\u20131132","journal-title":"Nature"},{"key":"2053_CR54","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487\u20131491","journal-title":"Science"},{"key":"2053_CR55","doi-asserted-by":"publisher","first-page":"e31754","DOI":"10.1371\/journal.pone.0031754","volume":"7","author":"V Lewis","year":"2012","unstructured":"Lewis V, Whitehouse IJ, Baybutt H, Manson JC, Collins SJ, Hooper NM (2012) Cellular prion protein expression is not regulated by the Alzheimer\u2019s amyloid precursor protein intracellular domain. PLoS One 7:e31754","journal-title":"PLoS One"},{"key":"2053_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-180054","volume":"64","author":"C Li","year":"2018","unstructured":"Li C, Gotz J (2018) Pyk2 is a novel tau tyrosine kinase that is regulated by the tyrosine kinase fyn. J Alzheimers Dis 64:205\u2013221","journal-title":"J Alzheimers Dis"},{"key":"2053_CR57","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1073\/pnas.0205689101","volume":"101","author":"R Li","year":"2004","unstructured":"Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R et al (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients. Proc Natl Acad Sci USA 101:3632\u20133637","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR58","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245\u20134249","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR59","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awq065","volume":"133","author":"JM Mc Donald","year":"2010","unstructured":"Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM et al (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328\u20131341","journal-title":"Brain"},{"key":"2053_CR60","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cne.21867","volume":"511","author":"P McMillan","year":"2008","unstructured":"McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, Greenup L et al (2008) Tau isoform regulation is region- and cell-specific in mouse brain. J Comp Neurol 511:788\u2013803","journal-title":"J Comp Neurol"},{"key":"2053_CR61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"2053_CR62","doi-asserted-by":"publisher","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","volume":"287","author":"S Mondragon-Rodriguez","year":"2012","unstructured":"Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N et al (2012) Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem 287:32040\u201332053","journal-title":"J Biol Chem"},{"key":"2053_CR63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, Polanco JC, Ittner LM, Gotz J (2015) Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol 129:207\u2013220","journal-title":"Acta Neuropathol"},{"key":"2053_CR64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/alzrt238","volume":"6","author":"HB Nygaard","year":"2014","unstructured":"Nygaard HB, van Dyck CH, Strittmatter SM (2014) Fyn kinase inhibition as a novel therapy for Alzheimer\u2019s disease. Alzheimers Res Ther 6:8","journal-title":"Alzheimers Res Ther"},{"key":"2053_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321\u2013332","journal-title":"Neuron"},{"key":"2053_CR66","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.nbd.2019.03.022","volume":"127","author":"T Ondrejcak","year":"2019","unstructured":"Ondrejcak T, Hu NW, Qi Y, Klyubin I, Corbett GT, Fraser G et al (2019) Soluble tau aggregates inhibit synaptic long-term depression and amyloid beta-facilitated LTD in vivo. Neurobiol Dis 127:582\u2013590","journal-title":"Neurobiol Dis"},{"key":"2053_CR67","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","volume":"38","author":"T Ondrejcak","year":"2018","unstructured":"Ondrejcak T, Klyubin I, Corbett GT, Fraser G, Hong W, Mably AJ et al (2018) Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo. J Neurosci 38:10595\u201310606","journal-title":"J Neurosci"},{"key":"2053_CR68","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.neurobiolaging.2013.05.019","volume":"34","author":"L Ordonez-Gutierrez","year":"2013","unstructured":"Ordonez-Gutierrez L, Torres JM, Gavin R, Anton M, Arroba-Espinosa AI, Espinosa JC et al (2013) Cellular prion protein modulates beta-amyloid deposition in aged APP\/PS1 transgenic mice. Neurobiol Aging 34:2793\u20132804","journal-title":"Neurobiol Aging"},{"key":"2053_CR69","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jnr.490390607","volume":"39","author":"L Otvos Jr","year":"1994","unstructured":"Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669\u2013673","journal-title":"J Neurosci Res"},{"key":"2053_CR70","doi-asserted-by":"publisher","first-page":"11062","DOI":"10.1073\/pnas.0609621104","volume":"104","author":"ET Parkin","year":"2007","unstructured":"Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC et al (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer\u2019s amyloid precursor protein. Proc Natl Acad Sci USA 104:11062\u201311067","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR71","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1083\/jcb.200304140","volume":"162","author":"PJ Peters","year":"2003","unstructured":"Peters PJ, Mironov A Jr, Peretz D, van Donselaar E, Leclerc E, Erpel S et al (2003) Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162:703\u2013717","journal-title":"J Cell Biol"},{"key":"2053_CR72","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1369\/jhc.4A6551.2005","volume":"53","author":"P Rezaie","year":"2005","unstructured":"Rezaie P, Pontikis CC, Hudson L, Cairns NJ, Lantos PL (2005) Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer\u2019s disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study. J Histochem Cytochem 53:929\u2013940","journal-title":"J Histochem Cytochem"},{"key":"2053_CR73","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.neurobiolaging.2011.12.032","volume":"33","author":"A Rijal Upadhaya","year":"2012","unstructured":"Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H et al (2012) Dispersible amyloid \u03b2-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Neurobiol Aging 33:2641\u20132660","journal-title":"Neurobiol Aging"},{"key":"2053_CR74","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awt362","volume":"137","author":"A Rijal Upadhaya","year":"2014","unstructured":"Rijal Upadhaya A, Kosterin I, Kumar S, Von Arnim C, Yamaguchi H, F\u00e4ndrich M et al (2014) Biochemical stages of amyloid \u03b2-peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically-preclinical Alzheimer\u2019s disease. Brain 137:887\u2013903","journal-title":"Brain"},{"key":"2053_CR75","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","volume":"16","author":"A Rijal Upadhaya","year":"2012","unstructured":"Rijal Upadhaya A, Lungrin I, Yamaguchi H, F\u00e4ndrich M, Thal DR (2012) High-molecular weight A\u03b2-oligomers and protofibrils are the predominant A\u03b2-species in the native soluble protein fraction of the AD brain. J Cell Mol Med 16:287\u2013295","journal-title":"J Cell Mol Med"},{"key":"2053_CR76","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316:750\u2013754","journal-title":"Science"},{"key":"2053_CR77","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1523\/JNEUROSCI.1873-18.2018","volume":"39","author":"SV Salazar","year":"2019","unstructured":"Salazar SV, Cox TO, Lee S, Brody AH, Chyung AS, Haas LT et al (2019) Alzheimer\u2019s disease risk factor Pyk2 mediates amyloid-beta-induced synaptic dysfunction and loss. J Neurosci 39:758\u2013772","journal-title":"J Neurosci"},{"key":"2053_CR78","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1523\/JNEUROSCI.0722-17.2017","volume":"37","author":"SV Salazar","year":"2017","unstructured":"Salazar SV, Gallardo C, Kaufman AC, Herber CS, Haas LT, Robinson S et al (2017) Conditional deletion of Prnp rescues behavioral and synaptic deficits after disease onset in transgenic Alzheimer\u2019s disease. J Neurosci 37:9207\u20139221","journal-title":"J Neurosci"},{"key":"2053_CR79","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M et al (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539\u20131550","journal-title":"Brain"},{"key":"2053_CR80","doi-asserted-by":"publisher","first-page":"e73696","DOI":"10.1371\/journal.pone.0073696","volume":"8","author":"S Senthivinayagam","year":"2013","unstructured":"Senthivinayagam S, McIntosh AL, Moon KC, Atshaves BP (2013) Plin2 inhibits cellular glucose uptake through interactions with SNAP23, a SNARE complex protein. PLoS One 8:e73696","journal-title":"PLoS One"},{"key":"2053_CR81","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41591-018-0206-4","volume":"24","author":"J Sepulcre","year":"2018","unstructured":"Sepulcre J, Grothe MJ, d\u2019Oleire Uquillas F, Ortiz-Teran L, Diez I, Yang HS et al (2018) Neurogenetic contributions to amyloid beta and tau spreading in the human cortex. Nat Med 24:1910\u20131918","journal-title":"Nat Med"},{"key":"2053_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropharm.2017.11.042","volume":"130","author":"LM Smith","year":"2018","unstructured":"Smith LM, Zhu R, Strittmatter SM (2018) Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer\u2019s model. Neuropharmacology 130:54\u201361","journal-title":"Neuropharmacology"},{"key":"2053_CR83","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nmeth947","volume":"3","author":"O Soderberg","year":"2006","unstructured":"Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3:995\u20131000","journal-title":"Nat Methods"},{"key":"2053_CR84","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205","journal-title":"Acta Neuropathol"},{"key":"2053_CR85","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287\u201313292","journal-title":"Proc Natl Acad Sci USA"},{"key":"2053_CR86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1440-1789.2010.01158.x","volume":"31","author":"RH Takahashi","year":"2011","unstructured":"Takahashi RH, Tobiume M, Sato Y, Sata T, Gouras GK, Takahashi H (2011) Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer\u2019s disease brain. Neuropathology 31:208\u2013214","journal-title":"Neuropathology"},{"key":"2053_CR87","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/sageke.2006.6.re1","volume":"2006","author":"DR Thal","year":"2006","unstructured":"Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowl Environ 2006:re1","journal-title":"Sci Aging Knowl Environ"},{"key":"2053_CR88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, R\u00fcb U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"key":"2053_CR89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1006\/exnr.2000.7380","volume":"163","author":"DR Thal","year":"2000","unstructured":"Thal DR, Holzer M, R\u00fcb U, Waldmann G, Gunzel S, Zedlick D et al (2000) Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 163:98\u2013110","journal-title":"Exp Neurol"},{"key":"2053_CR90","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.neurobiolaging.2006.05.029","volume":"28","author":"DR Thal","year":"2007","unstructured":"Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H et al (2007) Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 28:1221\u20131230","journal-title":"Neurobiol Aging"},{"key":"2053_CR91","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"2053_CR92","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, R\u00fcb U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733\u2013748","journal-title":"J Neuropathol Exp Neurol"},{"key":"2053_CR93","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/NEN.0000000000000228","volume":"74","author":"T Tousseyn","year":"2015","unstructured":"Tousseyn T, Bajsarowicz K, Sanchez H, Gheyara A, Oehler A, Geschwind M et al (2015) Prion disease induces Alzheimer disease-like neuropathologic changes. J Neuropathol Exp Neurol 74:873\u2013888","journal-title":"J Neuropathol Exp Neurol"},{"key":"2053_CR94","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A et al (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15:1227\u20131235","journal-title":"Nat Neurosci"},{"key":"2053_CR95","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/nan.12233","volume":"41","author":"J van Eersel","year":"2015","unstructured":"van Eersel J, Stevens CH, Przybyla M, Gladbach A, Stefanoska K, Chan CK et al (2015) Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 41:906\u2013925","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2053_CR96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjogren M et al (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285:49\u201352","journal-title":"Neurosci Lett"},{"key":"2053_CR97","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","volume":"131","author":"B Vasconcelos","year":"2016","unstructured":"Vasconcelos B, Stancu IC, Buist A, Bird M, Wang P, Vanoosthuyse A et al (2016) Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo. Acta Neuropathol 131:549\u2013569","journal-title":"Acta Neuropathol"},{"key":"2053_CR98","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4161\/pri.3.2.9135","volume":"3","author":"JL Velayos","year":"2009","unstructured":"Velayos JL, Irujo A, Cuadrado-Tejedor M, Paternain B, Moleres FJ, Ferrer V (2009) The cellular prion protein and its role in Alzheimer disease. Prion 3:110\u2013117","journal-title":"Prion"},{"key":"2053_CR99","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-018-1953-5","volume":"137","author":"C Vergara","year":"2019","unstructured":"Vergara C, Houben S, Suain V, Yilmaz Z, De Decker R, Vanden Dries V et al (2019) Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol 137:397\u2013412","journal-title":"Acta Neuropathol"},{"key":"2053_CR100","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s12035-014-8793-7","volume":"51","author":"C Vergara","year":"2015","unstructured":"Vergara C, Ordonez-Gutierrez L, Wandosell F, Ferrer I, del Rio JA, Gavin R (2015) Role of PrP(C) expression in tau protein levels and phosphorylation in Alzheimer\u2019s disease evolution. Mol Neurobiol 51:1206\u20131220","journal-title":"Mol Neurobiol"},{"key":"2053_CR101","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1523\/JNEUROSCI.0789-09.2009","volume":"29","author":"B Vincent","year":"2009","unstructured":"Vincent B, Sunyach C, Orzechowski HD, St George-Hyslop P, Checler F (2009) p53-Dependent transcriptional control of cellular prion by presenilins. J Neurosci 29:6752\u20136760","journal-title":"J Neurosci"},{"key":"2053_CR102","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s004010100405","volume":"101","author":"T Voigtlander","year":"2001","unstructured":"Voigtlander T, Kloppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S et al (2001) Marked increase of neuronal prion protein immunoreactivity in Alzheimer\u2019s disease and human prion diseases. Acta Neuropathol 101:417\u2013423","journal-title":"Acta Neuropathol"},{"key":"2053_CR103","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11010-007-9664-6","volume":"310","author":"XF Wang","year":"2008","unstructured":"Wang XF, Dong CF, Zhang J, Wan YZ, Li F, Huang YX et al (2008) Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem 310:49\u201355","journal-title":"Mol Cell Biochem"},{"key":"2053_CR104","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-013-1083-z","volume":"125","author":"AD Watt","year":"2013","unstructured":"Watt AD, Perez KA, Rembach A, Sherrat NA, Hung LW, Johanssen T et al (2013) Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples. Acta Neuropathol 125:549\u2013564","journal-title":"Acta Neuropathol"},{"key":"2053_CR105","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-017-1790-y","volume":"135","author":"JC Watts","year":"2018","unstructured":"Watts JC, Bourkas MEC, Arshad H (2018) The function of the cellular prion protein in health and disease. Acta Neuropathol 135:159\u2013178","journal-title":"Acta Neuropathol"},{"key":"2053_CR106","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JAD-2010-101071","volume":"22","author":"IJ Whitehouse","year":"2010","unstructured":"Whitehouse IJ, Jackson C, Turner AJ, Hooper NM (2010) Prion protein is reduced in aging and in sporadic but not in familial Alzheimer\u2019s disease. J Alzheimers Dis 22:1023\u20131031","journal-title":"J Alzheimers Dis"},{"key":"2053_CR107","doi-asserted-by":"publisher","first-page":"e59554","DOI":"10.1371\/journal.pone.0059554","volume":"8","author":"IJ Whitehouse","year":"2013","unstructured":"Whitehouse IJ, Miners JS, Glennon EB, Kehoe PG, Love S, Kellett KA et al (2013) Prion protein is decreased in Alzheimer\u2019s brain and inversely correlates with BACE1 activity, amyloid-beta levels and Braak stage. PLoS One 8:e59554","journal-title":"PLoS One"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-019-02053-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02053-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T04:10:10Z","timestamp":1650514210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-019-02053-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":107,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02053-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"8 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DRT received consultant honorary from GE-Healthcare (UK), and Covance Laboratories (UK), speaker honorary from Novartis Pharma AG (Switzerland), travel reimbursement from GE-Healthcare (UK), and UCB (Belgium), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium). JR and MS were employees of Novartis Pharma Basel and SR is employee of Novartis Pharma Basel (Switzerland). CAFvA received honoraria from serving on the scientific advisory board of Nutricia GmbH (2014), Roche (2018) and Honkong University Research Council (2014) and has received funding for travel and speaker honoraria from Nutricia GmbH (2014\u20132015), Lilly Deutschland GmbH (2013\u20132016), Desitin Arzneimittel GmbH (2014), Biogen (2016\u20132018), Roche (2017\u20132018), and Dr. Willmar Schwabe GmbH&Co. KG (2014\u20132015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}